PHIO PHARMACEUTICALS CORP.

NASDAQ:PHIO
Annual Meeting

of Shareholders

MEETING DATE

09/28/2026
DEF 14A FILED
08/14/2026
PUBLISHED
08/14/2026 8:04 pm
TIME TO PUBLISH
08/16/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:PHIO· CUSIP 71880W501 · CLASS common stock, par value $0.0001 per share · CIK 0001533040

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

3
FOR
0
AGAINST
0
WITHHOLD
3
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
Election of directors
board
Routine
For
Board FOR · Duopoly unknown No divergence flagged

The Board nominated six director nominees for election at the Annual Meeting.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
Ratification of Grant Thornton, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026
auditor
Routine
For
Board FOR · Duopoly unknown No divergence flagged

The Audit Committee selected Grant Thornton for fiscal 2026 and disclosed no disagreements with BDO.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
3
Approval of an amendment to the 2020 Phio Pharmaceuticals Corp. Long Term Incentive Plan, as amended and restated, to increase the number of shares of common stock available for issuance thereunder by 1,500,000
compensation
Routine
For
Board FOR · Duopoly unknown No divergence flagged

No other changes to the 2020 Plan are proposed.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

3e4bf56176271e6bd4588a9236097e5150a42a1552f3aaad8cee5ed841a27cde

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates